| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGGACAGUCACGCGACGGGUUCUGGUCCAAAAACCGCCUAAGUGCUCCG… | 1523 nt | 0.4143 | |
| AGGACAGUCACGCGACGGGUUCUGGUCCAAAAACCGCCUAAGUGCUCCG… | 1556 nt | 0.4152 | |
| AGGACAGUCACGCGACGGGUUCUGGUCCAAAAACCGCCUAAGUGCUCCG… | 1834 nt | 0.4149 |
This gene encodes a mitochondrially localized enzyme that catalyzes the reversible formation of acetoacetyl-CoA from two molecules of acetyl-CoA. Defects in this gene are associated with 3-ketothiolase deficiency, an inborn error of isoleucine catabolism characterized by urinary excretion of 2-methyl-3-hydroxybutyric acid, 2-methylacetoacetic acid, tiglylglycine, and butanone. [provided by RefSeq, Feb 2009]
A study in rats identified the ACAT1 as a key fatty acid metabolism-related gene that is downregulated in erectile dysfunction (ED) samples and demonstrated its high predictive efficacy for ED occurrence with an area under the curve value >0.8 [He et al. DOI:10.1093/sexmed/qfae011]. In human subcutaneous adipose tissue from BMI-discordant monozygotic twins, the ACAT1 was identified as a shared gene involved in isoleucine degradation and ketogenesis pathways, with its specific expression behavior in heavy co-twins detailed within the context of these metabolic pathways [Muniandy et al. DOI:10.1038/ijo.2017.95].